Suomen Hoivatilat Oyj: Change in the number of shares and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
28
Suomen Hoivatilat Oyj: Change in the number of shares and voting rights

Suomen Hoivatilat Oyj                                                   Stock exchange release 28 March 2017 at 1:30 pm

Suomen Hoivatilat Oyj: Change in the number of shares and voting rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

Suomen Hoivatilat Oyj: Change in the number of shares and voting rights

Suomen Hoivatilat Oyj ("Hoivatilat" or the "Company") announced the result of the offering (the "Offering") of preliminarily up to 3.5 million new shares (the "Offer Shares") in a stock exchange release published on 24 March 2017. Hoivatilat reserved the right of issuing a higher number of Offer Shares in the Offering than the planned preliminary maximum number of Offer Shares. In aggregate 4.5 million Offer Shares were issued in the Offering.

The 4,500,000 Offer Shares issued in the Offering have been registered in the Trade Register maintained by the Finnish Patent and Registration Office as of today. The aggregate number of shares in Hoivatilat and the number of votes conferred by the shares is 25,288,859. Each share confers one vote.

The Offer Shares issued in the Offering are new Hoivatilat shares that are equivalent to the existing share class of Hoivatilat. The ISIN code of the shares (including the Offer Shares) is FI4000148648.

Nasdaq Helsinki Ltd (the "Helsinki Stock Exchange") has today approved Hoivatilat's application for the admission into trading of the Offer Shares on the official list of the Helsinki Stock Exchange. Trading in the Offer Shares on the official list will commence on 29 March 2017.

Skandinaviska Enskilda Banken is acting as the Sole Bookrunner of the Offering. Krogerus Attorneys Ltd is acting as legal advisor to the Company in the Offering. Roschier Attorneys Ltd is acting as legal advisor to the Sole Bookrunner in the Offering.

Suomen Hoivatilat Oyj Board of directors

Further information: Suomen Hoivatilat Oyj CEO Jussi Karjula, tel.: +358 40 773 4054

Skandinaviska Enskilda Banken Director Juho Puhakainen, tel.: +358 50 3760 592

Suomen Hoivatilat in brief: Suomen Hoivatilat Oyj specialises in producing, developing, owning and leasing out nursing homes, day care centres and service blocks. Hoivatilat was founded in 2008, and the company has been working in cooperation with as many as approximately 50 Finnish municipalities and launched over 100 property projects around Finland. The company was listed on the official list of Nasdaq Helsinki Ltd on 1 March 2017. IMPORTANT INFORMATION

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

The Offering is not intended for the public. This release is not a prospectus and therefore not an offer relating to securities. No offer shall be made in any such jurisdiction in which the offer or participation therein would be unlawful or would require, in addition to any actions pursuant to Finnish law, the preparation of a prospectus, registration or any other action. The Sole Bookrunner is acting exclusively for the Company and no one else connected to the transaction pursuant to this release. The Sole Bookrunner will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for giving advice in relation to the contents of this release or the transaction pursuant to this release.

This release is directed only to (A) persons who are outside the United States of America; (B) (i) persons who are resident in a Member State of the European Economic Area (other than Finland) and are a qualified investor (within the meaning of Article 2(1)(e) of Directive 2003/71/EC and any relevant implementing measure in each Member State of the European Economic Area); or (ii) persons who are resident in Finland and are a qualified investor (within the meaning of Chapter 3, Section 5 of the Finnish Securities Markets Act (746/2012, as amended, in Finnish: kokenut sijoittaja); and (C) as regards Great Britain, (i) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); (ii) high net worth companies; and (iii) and other persons to whom it may lawfully be communicated, falling within Article 49(2) of the Order (all such persons together being referred to as "Relevant Persons"). Any Offer Shares or requests, offers or agreements relating to the subscription for, purchase of or any other acquisition of such Offer Shares are intended to be made available to Relevant Persons only. No one who is not a Relevant Person shall act on the basis of this release.

This release does not constitute an offer for the sale of securities in the United States. The Offer Shares may not be offered or sold within the United States absent of registration or an exemption under the U.S. Securities Act 1933 (as amended). The Company has not registered and it does not intend to register, any portion of the offering in the United States, and it does not intend to conduct a public offering in the United States.

This release contains forward-looking statements. These forward-looking statements are not based on historical facts, but are statements about future expectations. Statements included in this release which contain expressions "aims", "anticipates", "assumes", "believes", "estimates", "expects", "intends", "may", "plans", "should", and other similar expressions related to the Company or the Offering are examples of such forward-looking statements. Other forward-looking statements can be identified in the context in which the statements are made. Forward-looking statements contain information about future results, plans or expectations regarding the Company's business operations, including its strategy and growth plans and profitability, and the general economic situation. These forward-looking statements are based on current plans, estimates, prospects and expectations. They are based on certain currently valid expectations that may however turn out to be wrong. These forward-looking statements are based on assumptions and they contain several risks and uncertainties. Investors should not rely on these forward-looking statements. Several factors may result in a material deviation of the Company's actual business outcome or financial standing from the business outcome or financial standing that is indicated or referred to in forward-looking statements. The absence or occurrence of the aforementioned factors may cause a substantial deviation of the Company's actual business outcome or financial standing from what is directly or indirectly presented or described in the sections, which include forward-looking statements. Because of risks, uncertainties, assumptions and other factors, events described in forward-looking statements may not necessarily occur. Therefore, the accuracy and completeness or the occurrence of the predicted events of the forward-looking statements presented in this release cannot be guaranteed.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 4

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 8

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Imaging Techniques for Lung Cancer Treatment Success

Updated Category News Views 37

Revolutionary Techniques in Lung Cancer Management Onc.AI, a leading digital health innovator, is making strides in oncology clinical management with its pioneering approach toward imaging in advanced non-small cell lung cancer (NSCLC). The company focuses on integrating artificial intelligence into healthcare to enhance patient survival rates in cancer treatments....

Continue Reading
Kane Biotech Secures Funding Through Private Placement Initiative

Updated Category News Views 173

Kane Biotech Achieves Significant Milestone with Recent Funding Kane Biotech Inc. has recently made headlines by completing the first closing of its exciting non-brokered private placement offering. This strategic move is set to enhance the company’s capacity to innovate and expand its market presence. Private Placement Offering Details Under this newly announced...

Continue Reading
Apple Adjusts iPhone Air Production Amidst Strong Demand Shift

Updated Category News Views 183

Apple's Strategic Shift in iPhone Production Apple Inc. (NASDAQ:AAPL) has made a significant decision to decrease production orders for its iPhone Air while ramping up production for other flagship models like the iPhone 17. This change comes amid a surge in demand for these devices, particularly in markets that are seeing stronger consumer engagement. Weak Demand Impacts...

Continue Reading
Navigating Legal Proceedings: Insights for RxSight Investors

Updated Category News Views 273

A Comprehensive Guide for RxSight Investors Amid Legal Concerns Investors in RxSight, Inc. should be aware of the growing legal challenges facing the company. Robbins Geller Rudman & Dowd LLP is leading a class action lawsuit aimed at representing those who have faced significant financial losses while investing in RxSight (NASDAQ: RXST). This article delves into the...

Continue Reading
Reusable Laryngoscope System Market Growth Projections for 2034

Updated Category News Views 120

Tremendous Growth in the Reusable Laryngoscope System Market The reusable laryngoscope system market is on track for significant expansion, currently valued at around $920 million in the near term. With the healthcare industry increasingly leaning towards efficient and cost-effective solutions, this market is projected to reach approximately $1.8 billion by the year 2034....

Continue Reading